| Search Weight Loss Topics: |
Two Slimming Fats Could Help You Lose Weight – First For Women
Lose Weight Safely 
Comments Off on Two Slimming Fats Could Help You Lose Weight – First For Women
An unfortunate side effect of our increasing consumption of ultra-processed oils? Packing on hard-to-lose pounds. But theres a potential fix: Striking the right balance between certain kinds of dietary fat. Since forever, weve heard about dietary fats role in weight loss. Weve read about saturated and unsaturated fat and tried low-fat and high-fat plans; weve reached for handfuls of walnuts and forkfuls of fatty fish. But its been hard to determine exactly what to do to make a dent in our waistline. Thats where we come in! Read what the experts have to say about the fats that help you fight fat, and how to balance them to optimize their benefits below.
Experts have discovered an easy approach that involves eating the right daily balance of two essential fatty acids polyunsaturated fats known as omega-3s and omega-6s. In the simplest terms, omega-3s come from leaves (like spinach, seaweed, and Brussels sprouts) and the animals that eat them (grass-fed cattle and seaweed-snacking fish); omega-6s come from seeds, or nuts and grains (exceptions are flax and chia, both of which are rich in omega-3s).
Getting the right balance of these two omegas is the most important choice related to fats that you can make, contends nutrition researcher Anthony J. Hulbert, PhD. He pored over a centurys worth of data and concluded that people who eat lots of healthy omega-3s in relation to their omega-6 intake are slimmer. But unlike the minimum daily requirements that work for vitamins, its the balance between the two that matters, as they compete for space in our cells.
Health expert Marianna Moore recommends that adults consume 1.1 to 1.6 grams of Omega-3s daily and about 6.4 grams of omega-6s. But sadly, modern diets fall short. Today, women arent getting enough omega-3s, says Yale-trained Susan Allport, author of The Queen of Fats. Why? Our food supply has been flooded with omega-6s in processed food, at the expense of less shelf-stable omega-3s. Indeed, intake of omega-3s has dropped, says Dr. Hulbert. Instead, were unknowingly consuming processed omega-6 oils, thanks to restaurant fare and boxed food. In short: Dr. Hulbert says, Omega-6s fatten up our body like they do for livestock.
Once consumed, inflammatory omega-6s cause fat tissue to proliferate. They may also affect our endocannabinoid system, leading to inflammation and low mood. The downstream effects of that? One study found folks who ate the highest ratio of omega-6s to omega-3s gained more weight over a period of 10 years than those who didnt.
Weight-loss expert Fred Pescatore, MD, says, Youll never lose weight if your diet is tipped too far in the direction of pro-inflammatory omega-6s. By contrast, omega-3s may reduce fat-tissue growth. Says Dr. Hulbert, over time, as 3s replace 6s in cell membranes, those cells make less fat, so weight is easier to lose.
Thankfully, its not hard to achieve optimal omega balance. Just eat more omega-3rich foods and reduce your intake of fried or packaged foods. Allport explains, Before each meal, scan your plate and make sure you always have a source of omega-3s, like from fish, enriched eggs, or grass-fed meat or butter.
Slimming is just the start of the benefits. If you make sure youre getting more omega-3s than before, youll quickly lose weight, says Allport. You may also experience less joint pain, better skin, and strengthened immunity.
This content is not a substitute for professional medical advice or diagnosis. Always consult your physician before pursuing any treatment plan.
A version of this article originally appeared in our print magazine, First For Women.
More here:
Two Slimming Fats Could Help You Lose Weight - First For Women
What are weight loss injections and are they safe? – Patient.info
Lose Weight Safely Comments Off on What are weight loss injections and are they safe? – Patient.info
What are weight loss injections?
If you're considering weight loss injections, it's important to understand that this treatment is designed to address weight-related health issues. According to The National Institute for Health and Care Excellence (NICE)1, this medicine is only right for you if all of the following applies:
When it comes to weight loss, one size certainly doesn't fit all. If you don't meet these criteria but are unhappy with your size, speak to your GP about losing weight safely. This will always involve healthy eating and regular exercise, but there are various support services that can make your weight loss journey that little bit easier.
Saxenda - also known as liraglutide - is a weight loss medicine that you inject once a day to make you feel more full and less hungry.
This drug emulates a natural hormone found in the body that regulates your appetite, which can help you to consume fewer calories and lose weight. As with any weight loss treatment, this injection will only work if you also stick to a healthy diet and exercise plan. Studies show that Saxenda can lead to 4-6 kg of weight loss2.
In 2023, Wegovy - also called semaglutide - will join Saxenda and become the second injectable drug available on the NHS in England. In March 2023, NICE approved this popular US drug for the UK, concluding that it is a safe and effective weight loss treatment.
Like Saxenda, Wegovy makes you feel fuller for longer by mimicking an intestinal hormone. But while Saxenda is injected daily, Wegovy is injected weekly. There's also evidence that Wegovy may be more effective for weight loss than Saxenda3. According to NICE, the new drug may help people reduce their weight by more than 10%, so long as they follow their diet and exercise plans4.
There are other weight loss injections available in private practices, one of which, Aqualyx is a fat-dissolving injection that's widely available in the UK and is generally considered safe5, so long as it's administered by a trained healthcare professional.
A non-surgical alternative to liposuction, Aqualyx works by attaching to deposits of fat and gradually breaking them down until they are naturally flushed out of your body. As such, this injection can be used in a more targeted way than Saxenda and Wegovy, for example to decrease mass in your upper arms, stomach, or inner thighs.
These injections come with a hefty price tag. Although it varies between health providers, Saxenda pens cost roughly between 45 and 75. The costs quickly ramp up, given that the NHS recommends three months of treatment, and people tend to get through five injectable pens each month. Aqualyx is usually administered by a professional in two to four sessions, each visit costing upwards of 300. At this time, the price of Wegovy in the UK is unconfirmed until it's release later in 2023.
If you meet the criteria, Saxenda is now available for free through the NHS and on prescription in high-street pharmacists like Boots - and Wegovy will be soon. This is part of the NHS's bid to reduce healthcare costs attributed to weight-related health issues - projected to reach 9.7bn by 20506.
However, wait times are likely to be long, and your doctor may only recommend weight loss injections when other weight loss treatments have proven ineffective.
Saxenda is considered to be safe and is well-tolerated by most people7. Several clinical trials have also shown Aqualyx to be safe when administered correctly by a trained professional8, although there is less research for this drug than Saxenda.
However, like all medicines, there are possible side effects to consider.
The most commons side effects9 include:
There are a few documented cases of long-term and severe adverse reactions. These include:
It is not known if this medication can cause thyroid tumours or thyroid cancer, but medicines that work like Saxenda have caused these conditions in studies with rats. For this reason, you shouldnt take this injection if you or someone in your family has ever had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)9.
There are several other health conditions and medications that can make the Saxenda weight loss injection unsafe for you to take. Your healthcare expert will be able to advise if this is the case.
The most commons side effects10 include:
There are a few documented cases of long-term and severe adverse reactions. These include:
As with Saxenda, it is not known if Wegovy causes thyroid tumours or thyroid cancer, and so avoid this drug if you or someone in your family has ever had MTC or MEN 2. As other health conditions and medications may make Wegovy unsafe for you, always follow your healthcare experts advice.
The most common side effects usually clear within a few days. These include11:
The only serious adverse effects that have been reported are scarring and skin necrosis - where skin tissue dies resulting in a permanent visible dark mark12. These cases are very rare, but it should be noted that experts believe we need more studies of Aqualyx to fully understand exactly how safe and effective this drug is.
Remember, weight loss injections aren't miracle drugs - only by reducing your calorie intake, following a nutritious diet, and increasing your physical activity will you achieve a healthy body weight. It's these major lifestyle changes that will help you to keep the weight off and reduce your risk of weight-related health conditions.
In the UK, there have been reports of unregulated imports of weight loss injections and non-medically qualified practitioners. This weight management technique is only safe if carried out by a qualified and trained professional.
What to look for in a provider:
A trustworthy provider should always do a thorough check of your medical record and ask questions to determine if weight loss injections are a suitable and safe treatment path for you. You should disclose any current or previous medical conditions and medications that you have taken.
Read more from the original source:
What are weight loss injections and are they safe? - Patient.info
What Is Ozempic and Why Is It Getting So Much Attention? – The New York Times
Lose Weight Safely Comments Off on What Is Ozempic and Why Is It Getting So Much Attention? – The New York Times
Ozempic, a drug used to treat diabetes, keeps gaining attention as celebrities, a tech mogul and TikTok influencers have described taking it to lose weight in short time frames.
The Food and Drug Administration first approved the injectable medication for treating diabetes in 2017; the agency approved a drug with a higher dose of the active ingredient in Ozempic, called semaglutide, to treat obesity in 2021, under the brand name Wegovy. Since then, talk of the drug has popped up across the internet. Elon Musk, when asked about how he looked fit, ripped and healthy, tweeted that he was taking Wegovy. Andy Cohen posted about Ozempics growing popularity. In September, Variety reported that actors and producers are quietly singing the drugs praises on Signal, an encrypted messaging app. On TikTok, the hashtag #Ozempic has been viewed over 273 million times, with people alternately expressing shock over their supposed medication-induced weight loss and swapping stories about side effects. Thousands of people in Britain will soon be able to access Wegovy as well.
Now, the F.D.A. has listed both Ozempic and Wegovy as two of dozens of medications in short supply. A representative for Novo Nordisk, which manufactures the drugs, wrote in a statement that the company is experiencing intermittent supply disruptions on various doses of Ozempic due to the combination of incredible demand coupled with overall global supply constraints. The representative added that the shortage of Wegovy is likely to resolve soon, and that the company is on track to make all dose strengths of that drug available in December.
Its not unusual for doctors to prescribe medications for off-label use, or for a different purpose from what the medication is explicitly intended for, said Dr. Disha Narang, an endocrinologist at Northwestern Medicine Lake Forest Hospital. As interest in Ozempic has increased, some doctors believe that more people have sought ways to take the drug for weight loss either by finding a physician who will prescribe it to them off-label, or by seeking the drug out online. Dr. Narang herself has seen patients who have somehow gotten their hands on this, taking the medication off-label, she said. (Dr. Narang previously served on an advisory panel for Novo Nordisk, a common practice for experts in the field.)
She worries that, as the drug becomes increasingly popular, people will associate it with vanity, not as a critical medication for diabetes patients.
Heres what we know about what the medication can, and cant, do, and who should take it.
Ozempic and Wegovy are both designed to be injected once a week in the stomach, thigh or arm.
Semaglutide lowers blood sugar levels and regulates insulin, which is crucial for people with Type 2 diabetes. The drug also imitates a hormone called glucagon-like peptide-1 that we naturally produce in our intestines, limiting appetite by signaling to our bodies that we feel full and prompting our stomachs to empty more slowly. As a result, people with obesity and accompanying health concerns have lost weight while taking it. People feel fuller faster, said Dr. Janice Jin Hwang, chief of the division of endocrinology and metabolism at the University of North Carolina School of Medicine. For patients taking the medication, foods that used to be really exciting to them are no longer exciting, she said. The medication has not been significantly studied in people without diabetes or excess weight.
The medication can also reduce the risk of cardiovascular disease for people with diabetes, said Dr. Robert Gabbay, chief scientific and medical officer of the American Diabetes Association.
The F.D.A. has not approved Ozempic for weight loss, noted Dr. Andrew Kraftson, a clinical associate professor in the division of metabolism, endocrinology and diabetes at Michigan Medicine. But after the F.D.A. authorized Wegovy for weight loss, there was such demand for the drug that some providers turned to Ozempic when they couldnt get Wegovy, he explained.
Just as some people are prescribed medications to treat high blood pressure or high cholesterol indefinitely, some patients with obesity may be prescribed medications like Wegovy for a continuous period of time, Dr. Kraftson said. Those who discontinue taking the medication may regain weight lost while on Wegovy, he added.
These drugs were not designed for normal-weight people who want to get down to be super thin, Dr. Hwang said.
After the F.D.A. approved Ozempic for people with Type 2 diabetes, the agency approved Wegovy for adults with obesity or excess weight with at least one weight-related condition, which the agency considers to be issues like high blood pressure, Type 2 diabetes or high cholesterol. The F.D.A. defines obesity and overweight using the Body Mass Index, an entrenched but widely debated metric.
The medication is expensive without insurance the list price for Wegovy is over $1,300 for a 28-day supply, and Ozempic can cost around $892 for a monthly supply without insurance and people who dont meet the F.D.A.'s criteria will likely have trouble getting insurance to cover it.
Despite those obstacles, the rise in people using Ozempic off-label may be exacerbating the shortage, Dr. Narang said, noting that patients with diabetes and obesity are struggling to access it.
Its been really, really terrible patients dont know where to turn, she said. Weve been like hamsters in a wheel trying to figure this out.
While we recognize that some health care providers may be prescribing Ozempic for patients whose goal is to lose weight, it is up to the clinical discretion of each health care provider to choose the best treatment approach for their patients, a representative from Novo Nordisk wrote in a statement, adding that the company does not promote, suggest or encourage off-label use of our medications.
People taking Ozempic and Wegovy for both F.D.A. approved and off-label use may experience nausea and dehydration. They might also feel fatigue and malaise. Their bowel movements might change, with some patients having diarrhea and others becoming severely constipated. It can be so bad that people go to the E.R., Dr. Kraftson said. Its no joke. Patients should be monitored while taking these drugs, he said, and doctors may prescribe anti-nausea medications and laxatives or stool softeners. In rare cases, the medication could increase the risk of pancreatitis, a painful condition that inflames the pancreas. Some patients might also form gallstones. Dr. Gabbay said he had seen some patients with such severe vomiting that they had to stop taking the medication.
Doctors typically start patients on a lower dose of medications like Ozempic and Wegovy and then gradually build up, to minimize these side effects, Dr. Gabbay said.
Doctors say there isnt enough evidence to know whether these drugs might be beneficial or dangerous for people who fall outside of the F.D.A.s criteria. As tempting as the prospect of a drug for weight loss may be, experts cautioned against people seeking out the medication for off-label use. People who take Ozempic and Wegovy should be closely monitored, Dr. Kraftson said. If youre just getting this online, theres not going to be the same layers of protection, he said. I dont want to see people playing roulette with their health.
The drug has not been systematically tested in people with lower body weights, Dr. Hwang said, and its possible that patients outside of the group the drug is intended for could experience more intense side effects. Without more research, its unclear just how damaging those side effects could be.
Marching into the unknown is associated with some potential risk, Dr. Gabbay said. And we dont know what that is.
View post:
What Is Ozempic and Why Is It Getting So Much Attention? - The New York Times
Mount St. Mary’s Softball Tops CCSU, Edged by St. Bonaventure at … – Mount St. Mary’s Athletics
Hgh Comments Off on Mount St. Mary’s Softball Tops CCSU, Edged by St. Bonaventure at … – Mount St. Mary’s Athletics
Story Links Emmitsburg, Md. (March 11, 2023)--Mount St. Mary's defeated Central Connecticut, 5-2, to open the Mount Softball Invitational behind a two-hitter from freshman pitcher Maddie Coleman. The Mountaineers were edged by St. Bonaventure, 4-2, in the second game of the day. The Mountaineers are now 4-11 on the season.
MOUNT ST. MARY'S 5, CENTRAL CONNECTICUT 2
Freshman Maddie Coleman tossed a complete-game two hitter to lead Mount St. Mary's to a 5-2 win over Central Connecticut in the opening game on Saturday afternoon. The Mount scored four times in the bottom of the first to take control of the game.
Abigayle Perry walked to start the four-run first inning for the Mount, and advanced to second on a Maggie Kane sacrifice bunt. Hannah Gartrell singled to put runners on the corners, and Gartrell stole second to put two runners in scoring position. Brianna Manni then grounded to third, but reached on a fielder's choice to load the bases when the third baseman took too long holding the Perry at third base. Kaia Bonshock followed with a base hit just inside the first base line to bring home Perry and Gartrell for a 2-0 advantage. Mariah Godde was hit by a pitch to load the bases, and Zoe Wilcox drew a walk to force home the game's third run. Bonshock closed the scoring in the inning when she scampered home on a wild pitch.
The Blue Devils (3-5) got a run back in the top of the second. Ava Cino doubled with one out off Coleman. Grace Lawton then grounded out to third base with Cino advancing on the play. The ball got past Mount shortstop Godde, allowing Cino to score.
Mount St. Mary's got the run back in the bottom of the second. With one out, Kane doubled and Gartrell walked to put two runners on base. Manni followed with a single to center to plate Kane for a 5-1 advantage. Coleman maintained the advantage, allowing just one base runner over the next three innings. In the sixth, Brooke Fedison doubled, moved to third on a groundout, and scored on a Jazmin Lasane sacrifice fly to make it 5-2. Coleman closed out the game with a 1-2-3 top of the seventh.
Coleman allowed two runs (one earned) and just two hits in the complete-game effort for her first collegiate win. She struck out three and walked one in the seven innings.
ST. BONAVENTURE 4, MOUNT ST. MARY'S 2 (8 inn.)
Mount St. Mary's rallied from a two-run deficit, but fell to St. Bonaventure, 4-2, in eight innings in the game's second game. Mariah Godde had a pair of hits while Avery Neuhart struck out a season-hgh eight batters in a complete-game effort.
The Bonnies (2-8) opened the scoring with an unearned run in the top of the third inning. Brooke Bobbey singled to left to start the frame, and moved to second when the ball skipped by the Mount's left fielder. Grace Walker followed with a single to put runners on the corners, and then stole second to put the pair in scoring position. Emily Piergustavo followed with a sacrifice fly to score Bobbey with the game's first run.
St. Bonaventure made it a two-run lead in the fifth when Walker tripled and Piergustavo doubled. The Mount countered in the bottom of the frame to tie the game. Kassidy Johnson singled to open the inning and was replaced by pinch runner Julia Vincent. Godde followed with a double to right center field, but she overran second base. As St. Bonaventure was trying to get Godde out, Vincent was able to score on the play with Godde being safe at third. Vanessa Martin followed with a squeeze bunt to score Godde with the tying run.
Godde singled and stole second with two outs in the bottom of the seventh, but St. Bonaventure starter Emily Phelan got out of the jam with a pop out. In the eighth, the tiebreaker rule was instituted with a runner being place on second. Walker sacrificed Bobbey to third, and Piergustavo doubled to right field to give St. Bonaventure a 3-2 lead. After a wild pitch, a groundout brought home Piergustavo for an insurance run. Phelan retired the Mount in order in the eighth to preserve the win.
Neuhart allowed four runs (two earned) in eight innings in the complete game. She struck out a season-high eight batters while allowing just one walk.
Up Next: The Mount will host Central Connecticut at noon and St. Bonaventure at 2:00 p.m. tomorrow to close out the Mount Softball Invitational. CCSU and St. Bonaventure play at 10:00 a.m.
See the rest here:
Mount St. Mary's Softball Tops CCSU, Edged by St. Bonaventure at ... - Mount St. Mary's Athletics
Boston Red Sox star admits he would have been ‘perfect candidate’ for PEDs, but hates users – Sportsnaut
Hgh Comments Off on Boston Red Sox star admits he would have been ‘perfect candidate’ for PEDs, but hates users – Sportsnaut
Boston Red Sox pitcher Chris Sale knows that performance-enhancing drugs could have improved his career in a major way over the last few years, however, PED use was never an option since he despises those who take them.
In the previous decade, Chris Sale was one of the very best pitchers on the planet. He won 17 games three times during a run where he earned All-Star honors for seven straight seasons and was a consistent vote-getter for American League Cy Young.
Related: World Baseball Classic schedule Get watch times for tonights WBC games
However, it all changed in 2020 when he needed to undergo Tommy John surgery. In the two seasons after missing a year of action, he has only made 11 starts as he has constantly battled injuries and bad luck. His injury woes arent necessarily shocking later in his career because players with a wiry frame like his have often had difficulties long-term in combating the rigors of the sport.
Certainly, PED use could have kept him on the field more often, and the Boston Red Sox starter admitted as much during a recent appearance on the Baseball Isnt Boring podcast this week.
I wouldve been the perfect candidate my entire career to do [PEDs]. You know, everyone said I wasnt built to last, Sale said.
However, he claims PEDs were never an option since he has a deep disdain for fellow athletes that use them and gain their advantages. The 12-year veteran admits the benefits of PEDs are beyond just stats and have a huge effect on recovery. Something he could have used help with over the last few years, but even then the act of taking enhancers p***es him off too much to ever seriously consider them.
Your arm feels just amazing after two or three days off, and you feel 100% every time out. Thats just not fair. On top of that, now Im going through some injuries. Tommy John, some of these other things, and its like HGH wouldve helped me out tremendously in a short period of time. Obviously, in the long-term, there are long-term effects. I would never recommend anybody doing this ever.
But if I was just a cheater and selfish and whatever, I couldve done those things over this period of time, and I wouldve been stronger, I wouldve come back quicker, I wouldve felt better, and so on and so forth. So when I see other people doing that that dont even need it, it pisses me off.
Sale has already made a start in Boston Red Sox spring training and looks on track to be ready for the start of the season on March 30.
Continued here:
Boston Red Sox star admits he would have been 'perfect candidate' for PEDs, but hates users - Sportsnaut
Law firms sustain pandemic profits rise but WFH hurting productivity – Law Gazette
Hgh Comments Off on Law firms sustain pandemic profits rise but WFH hurting productivity – Law Gazette
Law firms managed to sustain the fillip to profits they earned on the back of the pandemic last year but fresh evidence has emerged that the working from home revolution may be damaging productivity.
These are among the findings of this years Law Society financial benchmarking survey, one of the sectors most respected annual bellwethers. Some 155 firms with average turnover of 7.1m took part, making the survey one of the largest of its type in England and Wales.
In 2021/22 median net profit per equity partner fell 1.8% on the previous year, from 203,577 to 199,846, according to analysis of firm accounts. But this followed a near 40% increase in 2020/21, when many firms posted their highest PEP figures ever. Fiscal breaks, furlough cash, a red-hot housing market and a slump in overheads as staff stayed at home were then major factors.
Confidence remains reasonably hgh as the 2022/23 financial year draws to a close. This years sample predicts median growth in projected fee income of 3.5% in 2023, with the upper quartile forecasting 10.1% and the lower a 2.5% cut. Anewly moribund property market and upward pressure on wages are among the factors inhibiting further growth.Total salary costs as a percentage of fee income increased by 0.4% last year, from 58.5% in 2021 to 58.9%.
Another notable finding of the survey is that working from home may be damaging productivity. The report points out that fee-earners should be charging at least 1,000 or 1,100 hours a year. But in 2021/22, the median number of chargeable hours actually fell, from 863 in 2021 to 841.
This supports the growing evidence that working from home is not always as beneficial to the firm as it is to the individual, the report concludes, noting: More and more firms are calling their staff back to the office for at least some of the week.
'It is encouraging to see law firms continuing to perform strongly, especially given the difficult economic climate we are all facing,' said Law Society president Lubna Shuja. 'As the cost-of-living crisis hits England and Wales, the legal sector will continue to be an important driver of the UKs economy.
'Of course, some firms struggle more than others, with lack of government investment continuing to hit legal aid firms. In this current crisis, lawyers are needed more than ever to help people access justice in their time of need. The government must take action to stop the shortfall in legal aid providers before it is too late.
*The Financial Benchmarking Survey 2023 is written and produced by the legal team of Hazlewoods LLP for the Law Society Leadership and Management Section, and sponsored by Lloyds Bank Commercial Banking. It is free to read in full here
Read the original:
Law firms sustain pandemic profits rise but WFH hurting productivity - Law Gazette
Man Hopes to Lose Weight By Eating Only McDonald’s – Eat This, Not That
Lose Weight Fast Comments Off on Man Hopes to Lose Weight By Eating Only McDonald’s – Eat This, Not That
Anyone attempting to lose weight or eat more healthfully likely tries to avoid fast food as much as possible. But instead of running away from it, one Tennessee man with a unique diet strategy is embracing fast food with open arms.
Kevin Maginnis, a 56-year-old business coach from Nashville, is committed to eating solely McDonald's for 100 days as part of his plan to lose weight and improve his cardiovascular health. He first spoke about the personal project in a February TikTok video that has received nearly two million views, saying that he weighed in at 238 pounds that morning and decided that that was "completely unacceptable."
RELATED:6 Healthiest McDonald's Breakfast Items, According to a Dietitian6254a4d1642c605c54bf1cab17d50f1e
The main rule of his diet is that he eats three McDonald's meals a day, but only consumes half of the portion. Additionally, whatever he doesn't finish during one meal, he saves to eat during another. However, one major swap he's making with his McDonald's orders is in the drink departmenthe's drinking water instead of soda.
He acknowledged that McDonald's may seem like a strange selection for his diet, but said that he's trying to make an important point by singling out the fast food giant.
"I know some of you are thinking that might be crazy, but I'm going to eat nothing but McDonald's for the next 100 days," he said. "But instead of eating everything they give me, I'm going to go ahead and cut the meals in half just to kind of prove to myself and maybe some of the people watching that it's not as much what you're eating. It's the quantity that we're eating that really jacks us up."
During a recent appearance on Tucker Carlson Tonight where he discussed the McDonald's diet even further, Maginnis said that he makes sure to "seek the heat" before he eats. This means that he waits until he can feel the hunger, or "heat," in his stomach before consuming any food.
"Everyone else calls it hunger. I call it my incinerator turning on to get rid of all the excess and also burn off some of the fat off my body, and then I'll have that next meal."
If this reminds you of the 2004 documentary Super Size Me, you're not alone. Several TikTokers pointed out the parallels between Maginnis' diet and filmmaker Morgan Spurlock's film, which explored the negative physical and mental effects of consuming nothing but McDonald's for one month.
Responding to one of these TikTokers, Maginnis referred to his own weight loss journey as " size me."
For any remaining skeptics, Maginnis has continued to document his experience on TikTok and claims that he's already seeing progress. In his most recent video posted today, which marks day 14 of the 100-day diet, he said that he was already down 16 pounds.
In the longer term, Maginnis believes that he'll be able to more than triple what he's already lost. While speaking to Carlson, he predicted that he'll be able to drop 50 pounds by the end of the 100 days and end up with better blood work and better overall health.
"You don't believe me? Just follow along, let's find out," he told Carlson.
Sign up for our newsletter!
Zoe Strozewski
View post:
Man Hopes to Lose Weight By Eating Only McDonald's - Eat This, Not That
Fairview man goes viral after eating McDonalds and losing weight – WSVN 7News | Miami News, Weather, Sports | Fort Lauderdale
Lose Weight Fast Comments Off on Fairview man goes viral after eating McDonalds and losing weight – WSVN 7News | Miami News, Weather, Sports | Fort Lauderdale
FAIRVIEW, Tennessee (WSMV) When trying to lose weight you might avoid McDonalds. But one Fairview man says thats the only place he turned to.
When its lunch hour at the Fairview McDonalds, for most people in the drive-thru line its their first Mickey Ds trip of the day.
For Kevin Maginnis, its his second. In fact, for the past 17 days hes gone to the fine fast-food establishment for every meal.
The trick is he only eats half the portion hes given.
This isnt supersized me; this is half size me, says Maginnis.
Hes on a mission to lose 50 pounds in 100 days.
Nothing else has gone in my body, not even a breath mint, Maginnis adds.
Its a journey he started with his very first TikTok that went viral with 2-million views. In it, he says he was originally at 238 pounds, which was unacceptable, so he went to McDonalds.
With millions of people watching, theres no way Im going to slip up and accidentally over eat and eat the whole thing, Maginnis says.
If its working for him, kudos to him, says Dr. Gitanjali Srivastava, a weight-loss doctor at Vanderbilt University Medical Center.
She says Maginnis diet isnt for everyone and people should focus on eating unprocessed foods like fruits, vegetables, and whole grains.
There are harmful effects for a long term processed diet, says Srivastava. It can have detrimental effects on our cholesterol, our glucose, all of those levels.
I have a lot of people who say this isnt healthy, dont believe that its good, youre going to kill yourself, rest in peace, says Maginnis. For all of them I say follow along, lets find out.
He says he doesnt care what some doctors have to say. He is down 18 pounds already by eating half his meals and taking the rest home for dinner.
Thats something Maginnis will be doing for the next 83 days.
Can we just fast forward to the end? he says. Can we just go right there and see what it turns out to be?
Maginnis says he checked in with doctors and cardiologists. They say he is in good shape right now.
Excerpt from:
Fairview man goes viral after eating McDonalds and losing weight - WSVN 7News | Miami News, Weather, Sports | Fort Lauderdale
Keto Light Plus Reviews – Does This Weight Loss Drink Really Work? Good For Health? Safe Ingredients? What Do Other Users Say? Read Before You Buy…
Lose Weight Fast Comments Off on Keto Light Plus Reviews – Does This Weight Loss Drink Really Work? Good For Health? Safe Ingredients? What Do Other Users Say? Read Before You Buy…
What to know about prescription drugs promising weight loss – theday.com
Lose Weight Fast Comments Off on What to know about prescription drugs promising weight loss – theday.com
WeightWatchers, the 60-year-old diet firm, announced last week it would acquire a telehealth company whose providers prescribe anti-obesity drugs for growing numbers of eager online subscribers.
The $132 million deal with Sequence is the just the latest commercial push into the red-hot market for prescription drugs that promise significant weight loss. For months, the diabetes drug Ozempic has been touted on social media by celebrities even though its not approved for weight loss. The demand for it sparked shortages.
WeightWatchers will be introducing its roughly 3.5 million subscribers to a new generation of medications that go beyond behavioral changes like gym workouts and diet tracking. Obesity experts say the drugs may revolutionize treatment of the disease that affects 42% of American adults.
Heres a look at the promise of these new medications and cautions about their use.
WHAT ARE THESE NEW DIET DRUGS?
The drugs that have generated most buzz are from a class of medications called GLP-1 agonists. Two of the most popular, Ozempic and Wegovy, are different doses of the same drug, semaglutide.
Ozempic has been used for six years to treat type 2 diabetes and is not approved for weight loss. Wegovy was approved in 2021 to treat obesity in adults and late last year to treat kids and teens 12 and older.
Doctors prescribe the medications to people with diabetes alone, or to people who are obese or who are overweight with additional health problems. Most of these types of drugs are delivered through weekly injections.
Supply problems and soaring demand last year led to a shortage of the drugs, but Novo Nordisk, the manufacturer, said those have been replenished.
HOW DO THE DRUGS WORK?
They mimic the action of a gut hormone that kicks in after people eat, boosting the release of insulin, blocking sugar production in the liver and suppressing appetite.
A newer drug, called tirzepatide, mimics the action of two hormones for even greater effect. The Eli Lilly and Co. drug, sold under the brand name Mounjaro, is now approved to treat diabetes, but the FDA granted fast-track status to review it to treat obesity. A decision is expected this spring.
With lower appetite and a greater feeling of fullness, people using these drugs eat less and lose weight.
HOW EFFECTIVE ARE THE DRUGS?
In a clinical trial, adults who took Wegovy saw a mean weight loss of nearly 35 pounds, or about 15% of their initial body weight. Adolescents lost about 16% of their body weight.
A clinical trial of Mounjaro, which is still being studied, saw mean weight loss of 15% to 21% of body weight depending on the dose, compared with a weight loss of about 3% for people taking placebo, or dummy drug.
WHY NOT JUST DIET AND EXERCISE?
In a typical weight-loss program where participants rely only on diet and exercise, about a third of people enrolled will lose 5% or more of their body weight, noted Dr. Louis Aronne, director of the Comprehensive Weight Control Center at Weill Cornell Medicine.
Most people find it difficult to lose weight because of the bodys biological reactions to eating less, he said. There are several hormones that respond to reduced calorie intake to increase hunger and maintain body mass.
There is a real physical phenomenon, he said. There is a resistance mechanism that is a coordinated effort by the body to prevent you from losing weight.
WHAT ARE THE SIDE EFFECTS OF THE DRUGS?
The most common side effects are short-lived gastrointestinal issues such as nausea, vomiting, diarrhea, stomach pain and constipation.
Other possible side effects include thyroid tumors, cancer, inflammation of the pancreas, kidney and gallbladder and eye problems. People with a family history of certain thyroid cancers or a rare, genetic endocrine disorder should avoid the drugs.
WHAT SHOULD CONSUMERS WATCH OUT FOR?
These new medications could be an effective part of a multifaceted approach to weight loss, said Dr. Amy Rothberg, an University of Michigan endocrinologist who directs a virtual weight management and diabetes program called Rewind.
But she worries that programs like WeightWatchers are primarily interested in boosting enrollment and profits.
My hope is that they do their due diligence and have real monitoring of the patients taking the drugs, she said.
Its important to make sure that patients are taking the drugs for the intended purpose, to make sure theres no reason they shouldnt take the drugs and that theyre monitored for side effects, she said.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institutes Science and Educational Media Group. The AP is solely responsible for all content.
Continued here:
What to know about prescription drugs promising weight loss - theday.com